How many were laid off yesterday?

Quote
it would take a couple of years to validate the technology, that's assuming the performance is at par with MPS. With the money Sequenom is hemorraging every quarter, it will never make it to market. This is why the leadership at Sequenom is having a nutty when Illumina bought Verinata and not Sequenom. Sequenom fate is already sealed.
 






SQNM management suffers from acute hubris and thinks they are better than they really are. They have made mistake after mistake and the shareholders have paid the price. All that matters now is getting profitable no matter what.
 






Anonymous said:
JUST FOR YOUR INFORMATIN:
ILLUMINA SEQUENCERS WILL BE OBSOLETE FOR NIPT AS SEQUENOM MIGHT BE RUNNING ALL TESTS SOON ON THEIR OWN IMPACT DX MACHINES
ONCE APPROVED BY FDA 510K THEY MIGHT START
SEE CELLSCAPE FOR CMA IN NIPT
THIS WILL BE THE DEATH OF BIG ILLUMINA
imo
Click to expand...

what about the european patent that sequenom has ??

also the low risk market is about a year or more away.
 












Lab corp CEO here if you're not a profitable company and you're not a growth company then what are you you're an out of business company I guess the five dollars a share we offered to you last year is looking pretty good it's now off the table will offer four dollars a share please call by Monday at five so we can wrap this up thank you much love
 
























Speaking for the investors I completely agree with all of the above. Some of the sales reps are possibly worth keeping although it's hard to say w/o competent mgmt to judge.
 










































you people need to start reading the writing on the wall, Sequenom continues to lose millions ever quarter, Illumina controls the market (sequencers), makes money on every NIPT lab that runs a test, Illumina/Verinata is the only company making money here (small sales force, managed care contracts, and doesn't give the test away). Pretty soon IVD will be out which will enable every health system lab in the country to run their own NIPT test, moral of the story, Illumina continues to make money, Sequenom, Aroisa, and Natera will be long gone in about 12 months.
 






























Top Bottom
Back
Quote